These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

386 related items for PubMed ID: 7512718

  • 1. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor.
    Miettinen M, Lindenmayer AE, Chaubal A.
    Mod Pathol; 1994 Jan; 7(1):82-90. PubMed ID: 7512718
    [Abstract] [Full Text] [Related]

  • 2. Immunohistochemical expression of endothelial markers CD31, CD34, von Willebrand factor, and Fli-1 in normal human tissues.
    Pusztaszeri MP, Seelentag W, Bosman FT.
    J Histochem Cytochem; 2006 Apr; 54(4):385-95. PubMed ID: 16234507
    [Abstract] [Full Text] [Related]

  • 3. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34.
    Ruck P, Xiao JC, Kaiserling E.
    Arch Pathol Lab Med; 1995 Feb; 119(2):173-8. PubMed ID: 7531428
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of anti-thrombomodulin antibody as a tumor marker for vascular neoplasms.
    Manning T, Smoller BR, Horn TD, El Darouti M, Marzouk S, Hadidi HE, Ramadan S.
    J Cutan Pathol; 2004 Nov; 31(10):652-6. PubMed ID: 15491324
    [Abstract] [Full Text] [Related]

  • 5. Lack of lymphatic vascular specificity of vascular endothelial growth factor receptor 3 in 185 vascular tumors.
    Partanen TA, Alitalo K, Miettinen M.
    Cancer; 1999 Dec 01; 86(11):2406-12. PubMed ID: 10590384
    [Abstract] [Full Text] [Related]

  • 6. Vascular endothelial growth factor receptor-3 (VEGFR-3): a marker of vascular tumors with presumed lymphatic differentiation, including Kaposi's sarcoma, kaposiform and Dabska-type hemangioendotheliomas, and a subset of angiosarcomas.
    Folpe AL, Veikkola T, Valtola R, Weiss SW.
    Mod Pathol; 2000 Feb 01; 13(2):180-5. PubMed ID: 10697276
    [Abstract] [Full Text] [Related]

  • 7. Co-expression of endothelial cell and macrophage antigens in Kaposi's sarcoma cells.
    Uccini S, Ruco LP, Monardo F, Stoppacciaro A, Dejana E, La Parola IL, Cerimele D, Baroni CD.
    J Pathol; 1994 May 01; 173(1):23-31. PubMed ID: 7523640
    [Abstract] [Full Text] [Related]

  • 8. The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.
    Schmidt D, von Hochstetter AR.
    Pathol Res Pract; 1995 Jun 01; 191(5):410-4. PubMed ID: 7479359
    [Abstract] [Full Text] [Related]

  • 9. Expression of D2-40 in lymphatic endothelium of normal tissues and in vascular tumours.
    Fukunaga M.
    Histopathology; 2005 Apr 01; 46(4):396-402. PubMed ID: 15810951
    [Abstract] [Full Text] [Related]

  • 10. Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.
    Siitonen SM, Haapasalo HK, Rantala IS, Helin HJ, Isola JJ.
    Mod Pathol; 1995 Sep 01; 8(7):745-52. PubMed ID: 8539232
    [Abstract] [Full Text] [Related]

  • 11. CD40 antigen is expressed by endothelial cells and tumor cells in Kaposi's sarcoma.
    Pammer J, Plettenberg A, Weninger W, Diller B, Mildner M, Uthman A, Issing W, Stürzl M, Tschachler E.
    Am J Pathol; 1996 May 01; 148(5):1387-96. PubMed ID: 8623911
    [Abstract] [Full Text] [Related]

  • 12. Quantification of angiogenesis in cervical cancer: a comparison among three endothelial cell markers.
    Vieira SC, Zeferino LC, Da Silva BB, Aparecida Pinto G, Vassallo J, Carasan GA, De Moraes NG.
    Gynecol Oncol; 2004 Apr 01; 93(1):121-4. PubMed ID: 15047224
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas.
    Kahn HJ, Bailey D, Marks A.
    Mod Pathol; 2002 Apr 01; 15(4):434-40. PubMed ID: 11950918
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prox-1 and VEGFR3 antibodies are superior to D2-40 in identifying endothelial cells of lymphatic malformations--a proposal of a new immunohistochemical panel to differentiate lymphatic from other vascular malformations.
    Castro EC, Galambos C.
    Pediatr Dev Pathol; 2009 Apr 01; 12(3):187-94. PubMed ID: 18937526
    [Abstract] [Full Text] [Related]

  • 17. Keratin 1 expression in endothelia and mesenchymal tumors: an immunohistochemical analysis of normal and neoplastic tissues.
    Remotti F, Fetsch JF, Miettinen M.
    Hum Pathol; 2001 Aug 01; 32(8):873-9. PubMed ID: 11521233
    [Abstract] [Full Text] [Related]

  • 18. Expression of matrix metalloprotease-9 in vascular pericytes in human breast cancer.
    Nielsen BS, Sehested M, Kjeldsen L, Borregaard N, Rygaard J, Danø K.
    Lab Invest; 1997 Oct 01; 77(4):345-55. PubMed ID: 9354769
    [Abstract] [Full Text] [Related]

  • 19. Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.
    Trojan L, Thomas D, Friedrich D, Grobholz R, Knoll T, Alken P, Michel MS.
    Anticancer Res; 2004 Oct 01; 24(3a):1651-6. PubMed ID: 15274336
    [Abstract] [Full Text] [Related]

  • 20. Prognostic value of von Willebrand factor, CD34, CD31, and vascular endothelial growth factor expression in women with uterine leiomyosarcomas.
    Poncelet C, Fauvet R, Feldmann G, Walker F, Madelenat P, Darai E.
    J Surg Oncol; 2004 May 01; 86(2):84-90. PubMed ID: 15112250
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.